✦ LIBER ✦

Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study

✍ Scribed by K. Krause; K. Weller; R. Stefaniak; H. Wittkowski; S. Altrichter; F. Siebenhaar; T. Zuberbier; M. Maurer

Book ID: 115089133
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 424 KB
Volume: 67
Category: Article
ISSN: 0105-4538
DOI: 10.1111/j.1398-9995.2012.02843.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot study to evaluate the safety and

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome

✍ Raphaela Goldbach-Mansky; Sharukh D. Shroff; Mildred Wilson; Christopher Snyder; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

Efficacy and safety of canakinumab in ur

Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study

✍ Krause, Karoline; Mahamed, Aos; Weller, Karsten; Metz, Martin; Zuberbier, Torste 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 544 KB

Long-Term Efficacy and Safety Profile of

Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study

✍ Hoffman, Hal M.; Throne, Martin L.; Amar, Niran J.; Cartwright, Robert C.; Kivit 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Efficacy and safety of rilonacept (inter

Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies

✍ Hal M. Hoffman; Martin L. Throne; N. J. Amar; Mohamed Sebai; Alan J. Kivitz; Art 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 1 views

An open-label extension study evaluating

An open-label extension study evaluating the efficacy and safety of oral tazarotene in plaque psoriasis

✍ Kim A Papp; Frederick Beddingfield; Susan Manrow; Patricia S. Walker 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

The efficacy and safety of terlipressin

The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study

✍ Yoshiyuki Narahara; Hidenori Kanazawa; Choitsu Sakamoto; Hitoshi Maruyama; Osamu 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 241 KB